180 Life Sciences Stock Jumps on $156 Million Notes Sale

Dow Jones
2025/08/12

By Dean Seal

 

Shares of 180 Life Sciences climbed after the company sold $156 million in convertible notes in order to load up its ether reserves.

The stock was up 11% at $3.32 in afternoon trading. Shares have now gained 83% since the start of the year.

The dietary supplement and food ingredient company said before the opening bell that it has sold $156 million worth of senior secured convertible notes due 2028 in a private offering.

The notes have a conversion price of $3.445 a share, subject to a one-time downward reset on the nine-month anniversary of the notes issuance if the closing price on that date is less than the conversion price.

Proceeds will be used to buy more ether for the company's ethereum treasury strategy.

 

Write to Dean Seal at dean.seal@wsj.com

 

(END) Dow Jones Newswires

August 11, 2025 13:34 ET (17:34 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10